Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Inovio a Bad-News Buy?

TheMotleyFool

0 0

You won't find many stocks that have been more volatile this year than Inovio Pharmaceuticals (NASDAQ: INO). We're talking about a biotech that saw its share price skyrocket more than 300% by early March, only to lose more than half of those gains within a matter of days. Just last month, Inovio's shares nearly doubled before plunging yet again.

Some investors have probably thrown in the towel on the beaten-down biotech stock. But could Inovio actually be a buy on bad news?

Image source: Getty Images.

Source Fool.com

Like: 0

INO

Share